The 2nd Novel Immunotherapeutics Summit of GTC

Why

Experts from academia and industry to discuss cutting edge research, immuno-strategies and novel findings and therapeutics against various diseases.
Representatives from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson & Johnson, Janssen Pharmaceuticals, Sanofi-Aventis, Eli Lilly, Merck, Pfizer, Amgen, Novo Nordisk, Dendreon, MedImmune, Athersys, Centocor, Elan, Biogen Idec, NIH, FDA, Genzyme, Harvard Medical School, Stanford University, MD Anderson Cancer Center, UC San Francisco and many more others.
Topics such as cytokines, inflam ation, cancer immunotherapy, biosimilars, immunomonitoring, therapeutic antibody, biomarkers, immunosuppression, immunogenicity, immunotoxicity etc. will be discussed.

When

On Jan 30 - Feb 1, 2013

Where

The Westin Gaslamp Quarter San Diego, CA, USA
910 Broadway Circle
San Diego, CA 92101

Agenda

The summit includes 4 concurrent conferences as well as an optional pre-summit workshop: